Case number 1:19-cv-01814
Horizon Medicines LLC et al v. Ajanta Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 13 | Motion for Leave to Appear Pro Hac Vice (2) |
| Feb 11, 2020 | 19 | Patent/Trademark Report to Commissioner (2) |
| Feb 11, 2020 | 19 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,345,695; 8,852,636; 8,858,996; 9,161,920; 9,198,888; 9,707,181. (Attachments: # (1) Notice of Voluntary Dismissal)(nms) |
| Feb 11, 2020 | 19 | Notice of Voluntary Dismissal (1) |
| Feb 11, 2020 | 18 | Notice of Voluntary Dismissal (1) Docket Text: NOTICE of Voluntary Dismissal by Horizon Medicines LLC, Nuvo Pharmaceuticals (Ireland) Designated Activity Company (Stover, Chad) |
| Feb 11, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [18]. (nms) |
| Feb 3, 2020 | 17 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Susan Krumplitsch as co-counsel.. (Stover, Chad) |
| Jan 21, 2020 | 16 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan & Bradford C. Frese - filed by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc.. (Pascale, Karen) |
| Jan 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Richard J. Berman, Janine A. Carlan and Bradford C. Frese, filed by Ajanta Pharma USA, Inc., Ajanta Pharma Ltd.. Signed by Judge Richard G. Andrews on 1/21/2020. (nms) |
| Jan 13, 2020 | N/A | SO ORDERED (0) |
| Jan 10, 2020 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Defendants' Motion to Dismiss to February 12, 2020 - filed by Horizon Medicines LLC, Nuvo Pharmaceuticals (Ireland) Designated Activity Company. (Stover, Chad) |
| Dec 16, 2019 | N/A | SO ORDERED (0) |
| Dec 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Susan Krumplitsch for Horizon Medicines LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Dec 13, 2019 | N/A | SO ORDERED (0) |
| Dec 13, 2019 | 13 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Susan Krumplitsch - filed by Horizon Medicines LLC, Nuvo Pharmaceuticals (Ireland) Designated Activity Company. (Attachments: # (1) Certification)(Stover, Chad) Modified on 12/13/2019 (nms). |
| Dec 13, 2019 | 13 | Certification by Counsel to be Admitted Pro Had Vice (1) |
| Dec 13, 2019 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order for Extension of Time - filed by Horizon Medicines LLC, Nuvo Pharmaceuticals (Ireland) Designated Activity Company. (Stover, Chad) Modified on 12/15/2019 (nms). |
| Dec 2, 2019 | 10 | Declaration (6) |
| Dec 2, 2019 | 10 | Exhibit 1 through 22 (435) |
| Dec 2, 2019 | 10 | Main Document (6) Docket Text: DECLARATION of Bradford C. Frese re [8] MOTION to Dismiss, by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc.. (Attachments: # (1) Exhibits 1-22)(Pascale, Karen) Modified on 12/3/2019 (nms). |
| Dec 2, 2019 | 8 | Motion to Dismiss/Improper Venue (4) Docket Text: MOTION to Dismiss - filed by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc.. (Pascale, Karen) Modified on 12/3/2019 (nms). |
| Dec 2, 2019 | 9 | Opening Brief in Support (20) Docket Text: OPENING BRIEF in Support re [8] MOTION to Dismiss, filed by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc..Answering Brief/Response due date per Local Rules is 12/16/2019. (Pascale, Karen) Modified on 12/3/2019 (nms). |
| Dec 2, 2019 | 11 | Declaration (5) Docket Text: DECLARATION Ramesh Jhawar, Ph.D. re [8] MOTION to Dismiss, by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc.. (Pascale, Karen) Modified on 12/3/2019 (nms). |
| Dec 2, 2019 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Ajanta Pharma Ltd. for Ajanta Pharma USA, Inc. filed by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc.. (Pascale, Karen) |
| Oct 29, 2019 | N/A | SO ORDERED (0) |
| Oct 28, 2019 | 7 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move against, answer or otherwise respond to the Complaint to December 2, 2019 - filed by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc.. (Pascale, Karen) |
| Oct 18, 2019 | N/A | SO ORDERED (0) |
| Oct 17, 2019 | 6 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to Complaint to October 31, 2019 - filed by Ajanta Pharma Ltd., Ajanta Pharma USA, Inc.. (Vrana, Robert) |
| Oct 2, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Sep 30, 2019 | N/A | Summons Reissued (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to Ajanta Pharma Ltd. (lak) |
| Sep 27, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Ajanta Pharma Ltd. on 9/27/2019; Ajanta Pharma USA, Inc. on 9/27/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (amf) |
| Sep 27, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nuvo Pharmaceuticals Inc. for Nuvo Pharmaceuticals (Ireland) Designated Activity Company and Corporate Parent Horizon Therapeutics plc (Ireland) for Horizon Medicines LLC - filed by Horizon Medicines LLC and Nuvo Pharmaceuticals (Ireland) Designated Activity Company. (amf) |
| Sep 27, 2019 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,345,695; 8,852,636; 8,858,996; 9,161,920; 9,198,888; and 9,707,181. (amf) |
| Sep 27, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/20/2019. Date of Expiration of Patent: 5/31/2022. Thirty Month Stay Deadline: 2/17/2022. (amf) (Main Document 3 replaced on 9/27/2019) (mal). |
| Sep 27, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf) |
| Sep 27, 2019 | 1 | Civil Cover Sheet (1) |
| Sep 27, 2019 | 1 | Exhibit F (22) |
| Sep 27, 2019 | 1 | Exhibit E (23) |
| Sep 27, 2019 | 1 | Exhibit D (23) |
| Sep 27, 2019 | 1 | Exhibit C (23) |
| Sep 27, 2019 | 1 | Main Document (34) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Ajanta Pharma Ltd. AND Ajanta Pharma USA, Inc. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number 0311-2741743) - filed by Horizon Medicines LLC and Nuvo Pharmaceuticals (Ireland) Designated Activity Company. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Civil Cover Sheet)(amf) |
| Sep 27, 2019 | 1 | Exhibit B (22) |
| Sep 27, 2019 | 1 | Exhibit A (22) |
| Sep 27, 2019 | 1 | Complaint (34) |
| Sep 27, 2019 | 1 | Complaint* (1) |
